For Medical Professionals

Sarcopenia is not normal aging.
It is a modifiable disease.

Loss of muscle mass, strength, and function begins as early as the thirties and accelerates with each passing decade — a silent, modifiable process and a leading, preventable driver of falls, disability, and lost independence later in life. The earlier it's addressed, the more your patients keep. Just Right Healthy Aging™ extends your care — delivering the personalized protein, supplement, vitamin D, and resistance-training support the guidelines call for, with a depth of follow-up that's hard to fit into a busy practice.

Physician Statement
"Resistance training, adequate protein, and vitamin D are not extras as we age. They are the foundation of staying strong, steady, and independent."
— Dr. Jeremy Burnham, MD
Aligned with the guidelines
USPSTFAmerican Heart AssociationAmerican Geriatrics SocietyESPEN · AWGS · EWGSOP2

Muscle loss is not
a cosmetic concern.

Skeletal muscle mass and strength begin to decline from the third decade of life, and the loss accelerates after 60. It is a defining feature of aging that patients are too often told to simply accept — yet it is modifiable at virtually any age.1

Age 30

is when the decline begins

Skeletal muscle mass and strength peak in early adulthood, then decline measurably from the third decade onward — silently, often for years before any symptoms appear.

Cruz-Jentoft & Sayer · Ref 1
18–27%

of lean mass lost across adulthood

Men lose roughly 18% of lean body mass between the second and eighth decades; women about 27% — a gradual erosion that is well underway by midlife.

Cruz-Jentoft & Sayer · Ref 1
18.8%

already affected by age 60+

of adults 60 and older meet criteria for sarcopenia (range 10–27%) — the predictable endpoint of decades of unaddressed decline.

Pooled meta-analyses · Ref 3, 4

Sarcopenia is not merely about muscle size. The European Working Group on Sarcopenia in Older People (EWGSOP2) defines it by low muscle strength as the primary criterion, combined with low muscle mass and/or low physical performance.2 It is now formally recognized as a disease, with its own diagnostic code (ICD-10-CM: M62.84).1

The clinical implication is straightforward: this is a condition to screen for, name, and treat — not a background process to observe. And because the underlying decline responds to exercise, protein, and targeted supplementation, the window for intervention opens decades earlier than most patients assume. The greatest returns come from acting in midlife — preserving and building muscle through the fifties and sixties — rather than waiting until frailty has already set in.

It is not a normal part of aging that patients must simply accept. It is a modifiable condition with devastating consequences when left unmanaged.
The clinical case for structured muscle preservation

The consequences are severe,
well-documented, and largely preventable.

Low muscle mass and strength are independent predictors of hard clinical outcomes across community-dwelling adults, outpatients, inpatients, and care-facility residents.1

2.0×
all-cause mortality, independent of definition and follow-up
HR 2.00 · Ref 5
3.6×
mortality in sarcopenia defined by EWGSOP criteria
OR 3.60 · Ref 6
3.0×
functional decline, with higher hospitalization & lost independence
OR 3.03 · Ref 6
2.8×
mortality with sarcopenic obesity — the worst cardiometabolic phenotype
HR 2.84 · Ref 7
Sarcopenia is associated with a 2- to 3.6-fold increase in mortality, a 3-fold increase in functional decline, and billions of dollars in preventable healthcare costs. The question is no longer whether structured muscle-preservation programs are needed as patients age — it is how to start them early enough and deliver them at scale, with personalization and consistency.

Sarcopenia is a direct, modifiable
contributor to falls.

Falls are the leading cause of injury-related morbidity and mortality among older adults in the United States — and sarcopenia is directly associated with increased fall risk (OR 1.60–1.89).6

27.5%

of community-dwelling adults 65+

reported at least one fall in the prior year. Falls remain the leading cause of injury death in this population.

CDC / USPSTF · Ref 8, 10
38,742

fall-related deaths in 2021

among Americans aged 65 and older — a toll that continues to rise year over year.

CDC · Ref 10
$50B+

in annual fall-related costs

in the U.S., the majority borne by Medicare — a largely preventable economic burden.

Florence et al · Ref 9

The U.S. Preventive Services Task Force (2024) recommends exercise interventions to prevent falls in community-dwelling adults 65 and older at increased risk — a B recommendation. Among the most commonly studied components are gait, balance, and functional training, followed by strength and resistance training, typically at a frequency of 2–3 sessions per week.8

Structured programs that combine resistance training, protein, vitamin D, and targeted supplementation represent the most evidence-based approach available for reducing this burden — addressing the muscle deficit that sits upstream of the fall, ideally years before a patient is ever at risk of one.

Every major body points
to the same approach.

Across aging, falls, and sarcopenia, the leading medical societies converge on a multimodal strategy combining exercise, protein optimization, and vitamin D. The evidence is consistent and compelling — and remarkably concordant from one guideline body to the next.81315

A 2024 New England Journal of Medicine review concluded that exercise and oral nutritional supplementation, alone or combined, can improve the frailty phenotype, enhance mobility and strength, and reduce falls — whereas single-target interventions, such as hormone therapy alone, have not.
Interventions affecting multiple physiological systems work; narrow ones do not19

Resistance training is now recognized as the primary countermeasure to sarcopenia — effective at every stage of adult life, from preserving peak muscle in midlife to rebuilding strength even in advanced age.1112

USPSTF 20248AHA Scientific Statement 202411AGS Consensus15ESPEN Expert Group13PROT-AGE14EWGSOP22

What clinicians know
vs. what they can deliver.

The evidence is clear. The guidelines are explicit. But the realities of practice stand between the recommendation and the patient.

Time

The visit can't hold it

The average primary-care or geriatric encounter does not allow for individualized protein calculations, resistance-training programming, supplement counseling, vitamin D optimization, and ongoing monitoring of muscle health.

Uptake

The single best intervention is the least used

Only about 19% of adults aged 65+ report resistance training twice a week or more — the lowest of any age group — despite it being the most effective intervention for sarcopenia.11

Detection

It remains widely underdiagnosed

Despite recognition as a disease (ICD-10-CM M62.84), screening is not routine. Many patients are identified only after a fall or fracture — when the window for prevention has already narrowed.1

Fragmentation

The expertise sits elsewhere

Referral pathways to exercise physiologists, dietitians, and physical therapists are often fragmented, unavailable, or not covered — leaving patients to navigate complex recommendations on their own.

The evidence is clear. The guidelines are explicit. The gap is delivery.

The evidence behind
each pillar.

Pillar 1 · Resistance Training

The primary countermeasure

A meta-analysis of 25 RCTs (2,267 participants) showed significant gains in lower-limb strength (ES 0.93), gait speed (ES 0.75), handgrip (ES 0.51), and muscle mass — in both early and late stages.12

The USPSTF (2024) recommends exercise to prevent falls, and the American Heart Association's 2024 Scientific Statement confirms that resistance training slows aging-related declines in muscle mass, power, strength, and function — with greater muscle mass independently associated with the prevention of injurious falls.811 Programs incorporating balance-challenge exercises may be most effective.

Pillar 2 · Protein

More is needed, not less

ESPEN and PROT-AGE recommend at least 1.0–1.2 g protein/kg/day for healthy older adults — well above the 0.8 g/kg RDA.1314

Aging muscle exhibits anabolic resistance — a higher per-meal threshold to stimulate the same muscle protein synthesis as in younger adults. Yet 23–27% of community-dwelling older adults fall short of even 1.0 g/kg/day. A 2026 umbrella review found combined exercise plus protein (≥1.2 g/kg/day) yielded superior gains in muscle mass and strength.13

Pillar 3 · Creatine + HMB

Two complementary pathways

Creatine

A meta-analysis of 357 older adults found creatine combined with resistance training increased fat-free mass (P < 0.0001), chest- and leg-press strength, and 30-second chair-stand performance versus resistance training alone.17

HMB (β-Hydroxy-β-Methylbutyrate)

The ISSN position stand confirms HMB acts through a dual mechanism: enhancing muscle protein synthesis via mTORC1 activation and suppressing breakdown via the ubiquitin-proteasome pathway. The AWGS consensus specifically notes HMB may be considered as part of nutritional support for muscle health.18

Pillar 4 · Vitamin D

Not too little, not too much

A 2025 Cochrane review found vitamin D probably reduces the rate of falls by ~37% in care-facility residents with low levels (RaR 0.63; 95% CI 0.46–0.86).16

The American Geriatrics Society recommends a minimum serum 25(OH)D of 30 ng/mL in older adults and supplementation of at least 800 IU/day for those at increased risk of falls.15 Critically, the relationship is dose-dependent in both directions — higher doses can paradoxically increase falls — which is why Just Right D™ personalizes dosing rather than applying a fixed amount.

What Just Right Healthy Aging™
provides for your patients.

Personalized protein assessment — individualized daily targets from age, body composition, current intake, and activity, aligned with ESPEN and PROT-AGE.

Daily HMB + creatine — evidence-based doses in a convenient daily format, combining anabolic support with anti-catabolic protection.

Personalized vitamin D (Just Right D™) — individualized assessment and six-month supply with reassessment, targeting the AGS minimum of 30 ng/mL while avoiding excessive dosing.

Smartphone-delivered resistance training — short, practical at-home exercises with balance and functional training, consistent with USPSTF and AHA. No gym required.

Physician-created education — why muscle matters with aging, how the program works, and when to consult their prescriber.

Six-month reassessment — because needs change as patients age and their health status evolves.

Why refer
your patients.

1

It aligns with every major guideline.

The USPSTF, AHA, AGS, EWGSOP2, ESPEN, and AWGS all recommend multimodal interventions combining exercise, protein optimization, and vitamin D for older adults at risk of sarcopenia and falls. Just Right Healthy Aging™ operationalizes these recommendations into a single, accessible program.8111315

2

It addresses the gap clinicians cannot fill.

Individualized protein planning, supplement dosing, resistance-training programming, and ongoing reassessment require time and expertise that most practices cannot provide at the frequency the evidence demands — and only 19% of older adults currently meet resistance-training guidelines.11

3

It targets the leading cause of injury death in older adults.

Falls cost the healthcare system over $50 billion annually, and sarcopenia is a direct, modifiable contributor to fall risk. A structured program combining resistance training, protein, vitamin D, and supplementation is the most evidence-based approach to reducing that burden.9

4

It complements — never replaces — your care.

The program is designed to work alongside the clinician's treatment plan. Patients are encouraged to share their program recommendations with their physician. No medications are prescribed, and no medical advice is given that supersedes the clinician's judgment.

5

It is evidence-based.

Every component — protein, creatine, HMB, vitamin D, and resistance training — is grounded in peer-reviewed research and endorsed or recommended by major medical societies as part of comprehensive healthy-aging care.1213161718

6

It prioritizes adherence.

The most effective program is the one patients actually follow. Supplements are delivered to the door. Exercises are delivered to the smartphone. Protein sources are chosen by the patient based on personal preference. It is designed for real life — not a clinical trial.

The question is no longer whether structured muscle preservation is needed — it's how to deliver it.

Two simple ways to begin. Request a referral kit for your practice, or book a short call to see how Just Right Healthy Aging™ fits the patients you're already treating.

Prefer email? Reach us directly at contact email.

Selected References

  1. Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636-2646. PubMed
  2. Cruz-Jentoft AJ, et al. Sarcopenia: revised European consensus on definition and diagnosis (EWGSOP2). Age Ageing. 2019;48(1):16-31. PubMed
  3. Petermann-Rocha F, et al. Global prevalence of sarcopenia and severe sarcopenia: a systematic review and meta-analysis. J Cachexia Sarcopenia Muscle. 2022;13(1):86-99. Link
  4. Systematic review & meta-analysis. Prevalence and factors associated with sarcopenia in community-dwelling older adults. Gerontology. 2026. PMC
  5. Xu J, et al. Sarcopenia is associated with mortality in adults: a systematic review and meta-analysis. Gerontology. 2022;68(4):361-376. PubMed
  6. Beaudart C, et al. Health outcomes of sarcopenia: a systematic review and meta-analysis. PLoS One. 2017;12(1):e0169548. PubMed
  7. Benz E, et al. Sarcopenia and sarcopenic obesity and mortality among older people. JAMA Netw Open. 2024;7(3):e243604. Link
  8. US Preventive Services Task Force. Interventions to prevent falls in community-dwelling older adults: USPSTF recommendation statement. JAMA. 2024;332(1):51-57. Link
  9. Florence CS, et al. Medical costs of fatal and nonfatal falls in older adults. J Am Geriatr Soc. 2018;66(4):693-698. PubMed
  10. Centers for Disease Control and Prevention. Older adult falls data (nonfatal falls 2018; fall deaths 2021). CDC
  11. Paluch AE, et al. Resistance exercise training in individuals with and without cardiovascular disease: 2023 update — a scientific statement from the American Heart Association. Circulation. 2024;149(3):e217-e231. Link
  12. Talar K, et al. Benefits of resistance training in early and late stages of frailty and sarcopenia: a systematic review and meta-analysis of RCTs. J Clin Med. 2021;10(8):1630. PMC
  13. Deutz NEP, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN Expert Group. Clin Nutr. 2014;33(6):929-936. PubMed
  14. Bauer J, et al. Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group. J Am Med Dir Assoc. 2013;14(8):542-559. PubMed
  15. American Geriatrics Society Workgroup on Vitamin D Supplementation for Older Adults. Recommendations abstracted from the AGS Consensus Statement on vitamin D for prevention of falls and their consequences. J Am Geriatr Soc. 2014;62(1):147-152. PubMed
  16. Dyer SM, et al. Interventions for preventing falls in older people in care facilities. Cochrane Database Syst Rev. 2025. Cochrane
  17. Devries MC, Phillips SM. Creatine supplementation during resistance training in older adults—a meta-analysis. Med Sci Sports Exerc. 2014;46(6):1194-1203. PubMed
  18. Rathmacher JA, et al. ISSN position stand: β-hydroxy-β-methylbutyrate (HMB). J Int Soc Sports Nutr. 2025;22(1):2434734. PubMed
  19. Frailty in older adults. Review of multimodal exercise and nutritional interventions. N Engl J Med (2024 review). PMC